Results 261 to 270 of about 107,331 (298)

Cyclooxygenase inhibitors: drugs for cancer prevention

Current Opinion in Pharmacology, 2003
Evidence that chronic intake of non-steroidal anti-inflammatory drugs, especially aspirin, prevents cancer development continues to accumulate. The data are particularly convincing for colorectal cancer; however, because of well-known side effects, they cannot routinely be recommended for this purpose.
Steven J, Shiff, Punitha, Shivaprasad, Diana L, Santini   +2 more
openaire   +2 more sources

The classification of cyclooxygenase inhibitors.

The Journal of rheumatology, 1998
Item does not contain ...
Lipsky, P.E., Abramson, S.B., Crofford, L.J., Dubois, R.N., Simon, L.S., Putte, L.B.A. van de   +5 more
openaire   +2 more sources

Cyclooxygenase Inhibitors

1985
Will J. Kort, Lorette O. M. Hulsman, Pieter E. Zondervan, Dick L. Westbroek   +3 more
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Selective Cyclooxygenase-2 Inhibitors

2004
Publisher Summary Cyclooxygenase (prostaglandin G/H synthase) catalyzes the conversion of arachidonic acid (AA) into prostaglandin H2 as the first committed step of prostaglandin biosynthesis. This enzyme is known to be the target of acetyl salicylic acid (ASA) and non-steroidal anti-inflammatory drugs (NSAIDs).
openaire   +1 more source

[Pharmacology and classification of cyclooxygenase inhibitors].

Gastroenterologie clinique et biologique, 2004
The discovery of at least two cyclooxygenase (COX) isoenzymes had two major consequences: i) to give a new impetus to the research on lipid metabolism, giving rise to the crystallization of these peculiar membrane enzymes, the characterization of their active sites and their gene regulation, and the identification of new metabolic pathways; ii) the ...
Jouzeau, Jean-Yves, Daouphars, Mikaël, Benani, Alexandre, Netter, Patrick   +3 more
openaire   +2 more sources

CYCLOOXYGENASE-2 INHIBITORS

Gastroenterology Clinics of North America, 1996
Jaime L. Masferrer, Peter C. Isakson, Karen Seibert   +2 more
openaire   +1 more source

[Coxibs: cyclooxygenase-2 inhibitors].

Wiener klinische Wochenschrift, 2001
The oxygenating enzyme cyclooxygenase (COX) catalysis the conversion of arachidonic acid to proinflammatory prostaglandins. For many years it was thought that COX is a single enzyme that is present constitutively in most tissues. But in the late 80ies COX activity was found to be increased in inflammatory states with cytokines and bacterial ...
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly